Protokinetix, Inc. is a research and development stage biotechnology company engaged in the scientific medical research of anti-aging glycoproteins. The company was founded by Grant Young on December 23, 1999 and is headquartered in Dalton, OH.
PKTX stock has fallen by 13.95% compared to the previous week, the month change is a 3.33% fall, over the last year ProtoKinetix, Inc. has showed a 42.91% decrease.
PKTX net income for the last quarter is −112.47 K USD, while the quarter before that showed −80.39 K USD of net income which accounts for −39.91% change. Track more ProtoKinetix, Inc. financial stats to get the full picture.
Today ProtoKinetix, Inc. has the market capitalization of 6.59 M, it has increased by 9.47% over the last week.
No, PKTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PKTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ProtoKinetix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
PKTX reached its all-time high on Jun 14, 2002 with the price of 2.1500 USD, and its all-time low was 0.0010 USD and was reached on Jul 17, 2013. See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ProtoKinetix, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ProtoKinetix, Inc. stock shows the sell signal. See more of ProtoKinetix, Inc. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.